[1]常丰葛,张 珂,马玉瑶,等.白花蛇舌草提取物对卵巢癌模型大鼠的疗效及对其血清性激素水平的影响*[J].陕西中医杂志,2019,(6):687-691.
 CHANG Fengge,ZHANG Ke,MA Yuyao,et al.Effect of hedyotis diffusa extract on ovarian cancer model rats and its effect on serum sex hormone levels[J].,2019,(6):687-691.
点击复制

白花蛇舌草提取物对卵巢癌模型大鼠的疗效及对其血清性激素水平的影响*
分享到:

《陕西中医》杂志[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年6期
页码:
687-691
栏目:
基础研究
出版日期:
2019-06-05

文章信息/Info

Title:
Effect of hedyotis diffusa extract on ovarian cancer model rats and its effect on serum sex hormone levels
文章编号:
DOI:10.3969/j.issn.1000-7369.2019.06.002
作者:
常丰葛1张 珂1马玉瑶1孙灵霞1 葛倩倩2
1.河南省许昌市人民医院妇科(许昌 461000);2.郑州大学第五附属医院妇产科(郑州 450007)
Author(s):
CHANG FenggeZHANG KeMA Yuyaoet al.
Department of Gynecology,Xuchang People Undefineds Hospital in Henan Province (Xuchang 461000)
关键词:
白花蛇舌草卵巢癌雌二醇促黄体生成素实验动物SD大鼠
Keywords:
Key words Hedyotis diffusaOvarian cancerEstradiolLuteinizing hormoneExperimental animals SD rats
分类号:
R737.31
文献标志码:
A
摘要:
摘 要 目的:研究白花蛇舌草提取物对卵巢癌大鼠的治疗效果及对大鼠雌二醇(E2)、孕酮(P)和促黄体生成素(LH)水平的影响。方法:选取健康SD大鼠30只,分为模型组、实验组和空白组,并对模型组和实验组大鼠进行卵巢癌模型建造,空白组不做处理。建模成功后给予实验组大鼠白花蛇舌草提取物注射治疗,对模型组和空白组大鼠注射等体积生理盐水干预,14 d后将所有大鼠断头处死,采集标本,HE染色后观察病理学组织图,并对三组大鼠的肿瘤重量平均值、腹水量平均值、肿瘤体积以及抑瘤率进行测量计算。采用化学发光法检测三组大鼠性激素水平,Western blot检测p38、NF 瘙 谞 kBp65蛋白相对表达,酶联免疫吸附测定法检测炎症指标TNF-α和IL-2水平。结果:实验组大鼠的肿瘤重量平均值、腹水量平均值以及肿瘤体积均显著低于模型组大鼠,抑瘤率明显高于模型组大鼠( P <0.05)。实验组大鼠性激素E2、P表达水平明显低于模型组大鼠,LH表达水平明显高于模型组大鼠( P <0.05)。实验组大鼠p38、NF-kBp65相对蛋白表达量相比模型组均显著降低,同时实验组大鼠TNF-α和IL-2水平相比模型组大鼠也明显下调( P <0.05)。结论:白花蛇舌草提取物能够改善卵巢癌大鼠的性激素水平,通过对p38/NF-kBp65信号通路来使机体内的炎症指标下降,从而抑制肿瘤的发展,为临床中卵巢癌的治疗和预后提供理论依据。
Abstract:
Abstract Objective: To study the effect of hedyotis diffusa extract on estradiol (E2), progesterone (P) and luteinizing hormone (LH) levels in ovarian cancer rats.Methods: 30 healthy SD rats were divided into model group, experimental group and blank group. The ovarian cancer model was established in model group and experimental group, and the blank group was not treated. After successful modeling, the rats in the experimental group were injected with the extract of Hedyotis diffusa, and the rats in the model group and the blank group were injected with the same volume of normal saline. After 14 days, all the rats were decapitated, and the specimens were collected. After HE staining, the pathological histogram was observed, and the average weight of the tumor and the average ascites volume of the three groups of rats were measured. The tumor volume and tumor inhibition rate were measured and calculated. Chemiluminescence was used to detect the levels of sex hormones, western blot to detect the relative expression of p38 and NF-kBp65 protein, and enzyme-linked immunosorbent assay to detect the levels of inflammatory markers TNF-a and IL-2. Results: The average weight, ascites and tumor volume of the experimental group were significantly lower than those of the model group, and the tumor inhibition rate was significantly higher than that of the model group ( P < 0.05). The relative protein expression of p38 and NF-kBp65 in the experimental group was significantly lower than that in the model group, and the levels of TNF-a and IL-2 in the experimental group were also significantly lower than those in the model group ( P <0.05).Conclusion:The extract of Hedyotis diffusa can improve the sex hormone level of ovarian cancer rats, through the p38 / NF-kBp65 signaling pathway to reduce inflammation index in the body, thus inhibiting the development of tumor, and provide an important theoretical basis for clinical treatment and prognosis of ovarian cancer.〖LM〗

参考文献/References:

[1] 刘 云,杜 成,刘文超,等.卵巢癌治疗新进展[J].现代肿瘤医学,2015,23(4):553-556.
[2]韩 萍,翟东霞,张丹英,等.耐药性复发卵巢癌治疗药物的研究进展[J].医学研究杂志,2018,47(1):171-174.
[3] Barreta A, Sarian L, Ferracini AC, et al . Endometriosis-associated ovarian cancer: population characteristics and prognosis[J]. Int J Gynecol Cancer,2018,28(7):1251-1257.
[4] 万小旭,张 行,王佳贺,等.白花蛇舌草的有效成分2-羟基-3-甲基蒽醌通过Fas/FasL信号通路诱导卵巢癌细胞凋亡[J].实用药物与临床,2015,18(12):1405-1409.
[5] 张 博,张 颖,牛力春,等.MIF及HIF-1α在上皮性卵巢癌中的表达及其临床意义[J].陕西医学杂志,2016,45(6):734-736,750.
[6] 霍 亮,葛倩倩.参葵汤对卵巢癌模型大鼠淋巴细胞、免疫球蛋白及相关炎症因子的影响[J].陕西中医,2018,39(8):995-997.
[7] Huang X, Wang X, Shang J, et al . Association between dietary fiber intake and risk of ovarian cancer: a meta-analysis of observational studies[J]. J Int Med Res,2018,24(8):300.
[8] 林兰娟,曾勇梅,李水云,等.黄芪扶正汤对卵巢癌术后化疗患者免疫功能的影响[J].陕西中医,2017,38(2):217-219.
[9] 陈藕景,祝 莹.血清肿瘤标志物在卵巢癌早期诊断中的临床价值[J].中国性科学,2016,25(3):48-50.〖ZK)〗
[10] 刘克维,吕 刚,王 剑,等.白花蛇舌草注射液联合顺铂腹腔灌注治疗卵巢癌腹腔积液疗效分析[J].大家健康,2017,11(12):99-100.
[11] 李文婷,戴紫函,程海波,等.白花蛇舌草活性成分及其协同抗肿瘤机制研究进展[J].世界科学技术-中医药现代化,2015,17(3):670-674.
[12] 毛 宇,徐 芳,徐小娟,等.白花蛇舌草抗肿瘤成分及其作用机理研究进展[J].现代预防医学,2015,42(17):3128-3132.
[13] 文雪梅,陈 瑛,李 婷,等.白花蛇舌草对宫颈癌细胞增殖、凋亡及Ki-67表达的影响[J].中国老年学杂志,2017,37(3):561-563.
[14] 刘志强,王博龙.基于网络药理学探讨白花蛇舌草主要成分的抗癌机制[J].中成药,2018,40(8):1827-1832.
[15] 罗天爱,苏 瑛,李 佳,等.雌激素受体在卵巢癌预后及治疗中的研究进展[J].现代妇产科进展,2018,27(2):156-158.
[16] 夏 红,初 磊,陈 艳,等.顺铂腹腔化疗对卵巢癌模型鼠雌激素影响的实验研究[J].同济大学学报:医学版,2015,36(2):16-19.
[17] 韩丽丽,王华杰,张慧慧,等.卵巢上皮性癌雌激素受体、孕激素受体的表达及与其预后的关系[J].中国实验诊断学,2016,20(7):1106-1108.
[18] 姚 娇,葛书霞,丁朝霞,等.卵巢癌细胞株SKOV3中ERβ表达对细胞增殖凋亡影响的研究[J].现代妇产科进展,2015,24(11):805-808,813.
[19] 南 燕,张恩娣.卵巢癌40例化疗前后血清中CA125、TNF-α和SIL-2R检测及意义[J].陕西医学杂志,2017,46(1):125-127.
[20] 邓 霖,王桂初.Survivin﹑ NF-κBp65﹑ IKB-α在卵巢上皮性肿瘤中的表达及意义[J].世界最新医学信息文摘,2015,18(5):52-53.
[21] 沈 玲,朱海超,杨秀丽, 等.胃癌患者Hp感染后P73与NF-kb和SOX2表达及临床病理特征的相关性研究[J].中华医院感染学杂志,2018,28(15):2261-2264.
[22] 邓 帅,高 峰,田 青.黄芩素对人肺癌细胞A549耐顺铂株顺铂细胞毒性及Akt/NF-kB信号通路关系分析[J].四川中医,2018,36(8):50-53.
[23] 伍振辉,孟 娴,胡佳伟, 等.TLR4-MyD88-NF-kB信号通路与肝炎-肝纤维化-肝癌轴相关性研究进展[J].国际药学研究杂志,2017,44(5):396-401.

相似文献/References:

[1]王沈峰,金 迎,周禄荣,等.益气活血法治疗卵巢癌及对患者血清人附睾蛋白4、间皮素及肿瘤标记物的影响研究*[J].陕西中医杂志,2020,(5):646.[doi:DOI:10.3969/j.issn.10007369.2020.05.026]
 WANG Shenfeng,JIN Ying,ZHOU Lurong,et al.Yiqi Huoxue method in the treatment of ovarian cancer and effects on serum HE4,SMRP and tumor markers[J].,2020,(6):646.[doi:DOI:10.3969/j.issn.10007369.2020.05.026]
[2]胡天祺,杨梦琪,杨 红,等.益气养阴方对卵巢癌术后患者化疗不良反应及生存质量的影响[J].陕西中医杂志,2021,(4):434.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.007]
 HU Tianqi,YANG Mengqi,YANG Hong,et al.Effect of Yiqi Yangyin recipe on the adverse reaction effects and quality of life in patients with ovarian cancer undergoing chemotherapy[J].,2021,(6):434.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.007]
[3]李成斐,朱 萍,于 佳,等.益气活血解毒方联合化疗治疗晚期卵巢癌疗效及对患者免疫通路相关靶基因的影响[J].陕西中医杂志,2021,(8):1072.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.021]
 LI Chengfei,ZHU Ping,YU Jia,et al.The effect of Yiqi Huoxie Jiedu decoction combined with TC regimen on advanced ovarian cancer and related target genes of immune pathway[J].,2021,(6):1072.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.021]
[4]王小玉,韩凤娟.基于“天癸-肾阳-命门”学说探究卵巢癌发病机制[J].陕西中医杂志,2021,(9):1261.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.029]
[5]陈双凤,吉亚南.温阳活血方对卵巢癌患者免疫指标及炎性因子的影响[J].陕西中医杂志,2021,(10):1371.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.011]
[6]刘少璇,李 佳,刘芳媛,等.基于“亢害承制”理论辨析卵巢癌因机证治[J].陕西中医杂志,2022,(7):925.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.027]
 LIU Shaoxuan,LI Jia,LIU Fangyuan,et al.An analysis of mechanism in ovarian cancer based on the theory of “restraining excessiveness to acquire harmony”[J].,2022,(6):925.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.027]

备注/Memo

备注/Memo:
*河南省医学科技攻关计划项目(201403124)
更新日期/Last Update: 2019-06-20